Very happy to share the latest work out in @SciImmunology. Here we use single cell RNA-sequencing in combination with an activation induced marker (AIM) assay to explore the impact of the COVID-19 vaccine regimen on T cell quality. With @PKlenermanLab@nprovine@NDMOxford
A new study finds that extended intervals between #SARSCoV2 mRNA vaccine doses lead to higher quality T cell responses and lower inflammation after vaccination in humans.
Learn more in @SciImmunology: https://t.co/jyHLazkXDK
Two new Science #Immunology studies provide insight into how different #COVID19#vaccine types and dosing intervals affect T cell responses in humans.
📄: https://t.co/JayNtDUG56
📄: https://t.co/suNNHkKjtW
Dosing interval is a major factor determining the quality of T cells induced by SARS-CoV-2 mRNA and adenoviral vector vaccines @SciImmunology@PKlenermanLab@nprovine 🇬🇧
https://t.co/eg07l1d5s8
🎉 Join us in Dublin City Centre to hear from four top immunology #yefis young scientists explain their research over a pint! Expect pints, craic, trivia and learning about cutting edge research. 🧬🔬
📍Register here: https://t.co/RInPKocXIm.
Introducing ‘Pint of Immunology’🍻
Join us Sept 2nd for a night of #immunology & pints for a European Congress of Immunology 2024 public outreach event!
Open to all- get your free but limited tickets now https://t.co/AvMRyd82x7
Please RT and share! @Irishimmunology@tcdTBSI
Very excited to present in this session tomorrow morning amongst some leaders in the field! Come along to hear about our work to understand vaccine-related immune signatures in people with immunosuppressive conditions! #AAI2024
Don’t miss IMMUNOLOGY2024™’s first Major Symposium: Incorporating Time and Space into Multi-omic Systems Immunology Analyses tomorrow at 8 am in Skyline Ballroom W375C. #AAI2024
📢Check our January issue ‼️
Featured article:
➡️A prospective, multicenter, three-cohort study evaluating contrast-induced #acutekidneyinjury (CI-AKI) in patients with #cirrhosis
🔗https://t.co/tJ8uTe67ZO
Full issue👉https://t.co/QHvXVi5lG8
#LiverTwitter@EASLnews@EASLedu
What do we know about #covid in immunocompromised people?
Katharine Lang looks at the continuing dangers of covid for immunocompromised people, the treatments available to them, and how antivirals such as remdesivir may help
https://t.co/jhmRX8N50K
Really pleased to share this work, investigating immune responses to COVID-19 vaccines in people with liver diseases and liver transplants from across Europe.
A huge collaborative effort led by the expert @tom_marjot and @EleanorBarnesOx.
@JHepatology@EASLnews@NDM_Papers
Delighted to see this out in @JHepatology
Immune responses & clinical outcomes across 3 #COVID vaccine doses. Includes longitudinal assessment of T cells & Ab in #cirrhosis, LT, AIH, VLD & HC
🔗https://t.co/bmMImtnoIt
Has been a privilege to work with such an amazing🌍 team👇
Extremely happy to share our latest work on #COVID-19 research identifying a genetic link with asymptomatic COVID infection.
How do people dodge #COVID?
https://t.co/rHkdb5Vl98
🧵below